-
1
-
-
0036829649
-
National Institutes of Health Consensus Development Conference Panel Statement: Management of hepatitis C: 2002-June 10-12, 2002
-
National Institutes of Health Consensus Development Conference Panel Statement: management of hepatitis C: 2002-June 10-12, 2002. Hepatology. 2002; 36(suppl):S3-S15.
-
(2002)
Hepatology
, vol.36
, Issue.SUPPL.
-
-
-
2
-
-
0033584440
-
The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
-
Alter M.J., Druszon-Moran D., Nainan O.V., et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 341:1999;556-562
-
(1999)
N Engl J Med
, vol.341
, pp. 556-562
-
-
Alter, M.J.1
Druszon-Moran, D.2
Nainan, O.V.3
-
3
-
-
0036815962
-
Global epidemiology and burden of hepatitis C
-
Kim W.R. Global epidemiology and burden of hepatitis C. Microbes Infect. 4:2002;1219-1225
-
(2002)
Microbes Infect
, vol.4
, pp. 1219-1225
-
-
Kim, W.R.1
-
4
-
-
0036829985
-
Introduction to therapy of hepatitis C
-
Lindsay K.L. Introduction to therapy of hepatitis C. Hepatology. 36:(suppl):2002;S114-S120
-
(2002)
Hepatology
, vol.36
, Issue.SUPPL.
-
-
Lindsay, K.L.1
-
5
-
-
0036016774
-
Impaired response to high-dose interferon treatment in African Americans with chronic hepatitis C
-
De Maria N., Colantoni A., Idilman R., et al. Impaired response to high-dose interferon treatment in African Americans with chronic hepatitis C. Hepatogastroenterology. 49:2002;788-792
-
(2002)
Hepatogastroenterology
, vol.49
, pp. 788-792
-
-
De Maria, N.1
Colantoni, A.2
Idilman, R.3
-
6
-
-
0034320232
-
Hepatitis C in African Americans: Summary of a workshop
-
Howell C., Jeffers L., Hoofnagle J.H. Hepatitis C in African Americans Summary of a workshop. Gastroenterology. 119:2000;1385-1396
-
(2000)
Gastroenterology
, vol.119
, pp. 1385-1396
-
-
Howell, C.1
Jeffers, L.2
Hoofnagle, J.H.3
-
7
-
-
0034914179
-
African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians
-
Kinzie J.L., Naylor P.H., Nathani M.G., et al. African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians. J Viral Hepatol. 8:2001;264-269
-
(2001)
J Viral Hepatol
, vol.8
, pp. 264-269
-
-
Kinzie, J.L.1
Naylor, P.H.2
Nathani, M.G.3
-
8
-
-
0034322373
-
The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C
-
McHutchison J.G., Poynard T., Pianko S., et al. The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. Gastroenterology. 119:2000;1317-1323
-
(2000)
Gastroenterology
, vol.119
, pp. 1317-1323
-
-
McHutchison, J.G.1
Poynard, T.2
Pianko, S.3
-
9
-
-
0036732708
-
US veterans' experience with Rebetron in a nonstudy environment: Success or failure?
-
Morelli J., Kim C.Y., Willner I.R. US veterans' experience with Rebetron in a nonstudy environment Success or failure? Am J Gastroenterol. 97:2002;2379-2382
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 2379-2382
-
-
Morelli, J.1
Kim, C.Y.2
Willner, I.R.3
-
10
-
-
0032841858
-
Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group
-
Reddy K.R., Hoofnagle J.H., Tong M.J., et al. Racial differences in responses to therapy with interferon in chronic hepatitis C. Consensus Interferon Study Group. Hepatology. 30:1999;787-793
-
(1999)
Hepatology
, vol.30
, pp. 787-793
-
-
Reddy, K.R.1
Hoofnagle, J.H.2
Tong, M.J.3
-
11
-
-
0037283618
-
Intensive interferon therapy does not increase virologic response rates in African Americans with chronic hepatitis C
-
Theodore D., Shiffman M.L., Sterling R.K., et al. Intensive interferon therapy does not increase virologic response rates in African Americans with chronic hepatitis C. Dig Dis Sci. 48:2003;140-145
-
(2003)
Dig Dis Sci
, vol.48
, pp. 140-145
-
-
Theodore, D.1
Shiffman, M.L.2
Sterling, R.K.3
-
12
-
-
0036829499
-
Southeast Asian patients with chronic hepatitis C: The impact of novel genotypes and race on treatment outcome
-
Dev A.T., McCaw R., Sundararajan V., et al. Southeast Asian patients with chronic hepatitis C The impact of novel genotypes and race on treatment outcome. Hepatology. 36:2002;1259-1265
-
(2002)
Hepatology
, vol.36
, pp. 1259-1265
-
-
Dev, A.T.1
McCaw, R.2
Sundararajan, V.3
-
13
-
-
0028234491
-
Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C
-
The French METAVIR Cooperative Study Group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology. 20:1994;15-20
-
(1994)
Hepatology
, vol.20
, pp. 15-20
-
-
-
14
-
-
0036129967
-
The natural history of HCV infection in African Americans
-
Mallat D.B., Jeffers L. The natural history of HCV infection in African Americans. Am J Gastroenterol. 97:2002;520-522
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 520-522
-
-
Mallat, D.B.1
Jeffers, L.2
-
15
-
-
0036129997
-
Hepatitis C infection in African Americans: Its natural history and histological progression
-
Wiley T.E., Brown J., Chan J. Hepatitis C infection in African Americans Its natural history and histological progression. Am J Gastroenterol. 97:2002;700-706
-
(2002)
Am J Gastroenterol
, vol.97
, pp. 700-706
-
-
Wiley, T.E.1
Brown, J.2
Chan, J.3
-
16
-
-
0034893191
-
Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles county
-
Bonacini M., Groshen S., Yu M.C., et al. Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles county. Am J Gastroenterol. 96:2001;2438-2441
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 2438-2441
-
-
Bonacini, M.1
Groshen, S.2
Yu, M.C.3
-
17
-
-
0035399634
-
Racial differences in HLA class II associations with hepatitis C virus outcomes
-
Thio C.L., Thomas D.L., Goedert J.J., et al. Racial differences in HLA class II associations with hepatitis C virus outcomes. J Infect Dis. 184:2001;16-21
-
(2001)
J Infect Dis
, vol.184
, pp. 16-21
-
-
Thio, C.L.1
Thomas, D.L.2
Goedert, J.J.3
-
18
-
-
0034788060
-
Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-α therapy
-
Kimball P., Elswick R.K., Shiffman M. Ethnicity and cytokine production gauge response of patients with hepatitis C to interferon-α therapy. J Med Virol. 65:2001;510-516
-
(2001)
J Med Virol
, vol.65
, pp. 510-516
-
-
Kimball, P.1
Elswick, R.K.2
Shiffman, M.3
-
19
-
-
0037369659
-
Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response
-
Sugimoto K., Stadanlick J., Ikeda F., et al. Influence of ethnicity in the outcome of hepatitis C virus infection and cellular immune response. Hepatology. 37:2003;590-599
-
(2003)
Hepatology
, vol.37
, pp. 590-599
-
-
Sugimoto, K.1
Stadanlick, J.2
Ikeda, F.3
-
20
-
-
0037237112
-
MHC class II genes in HCV viral clearance of hepatitis C-infected Hispanic patients
-
Azocar J., Clavijo O.P., Yunis E.J. MHC class II genes in HCV viral clearance of hepatitis C-infected Hispanic patients. Hum Immunol. 64:2003;99-102
-
(2003)
Hum Immunol
, vol.64
, pp. 99-102
-
-
Azocar, J.1
Clavijo, O.P.2
Yunis, E.J.3
-
21
-
-
0035880883
-
Commentary: Considerations for use of racial/ethnic classification in etiologic research
-
Kaufman J.S., Cooper R.S. Commentary Considerations for use of racial/ethnic classification in etiologic research. Am J Epidemiol. 154:2001;291-298
-
(2001)
Am J Epidemiol
, vol.154
, pp. 291-298
-
-
Kaufman, J.S.1
Cooper, R.S.2
-
22
-
-
0030792316
-
Race and health: Basic questions, emerging directions
-
Williams D.R. Race and health Basic questions, emerging directions. Ann Epidemiol. 7:1997;322-333
-
(1997)
Ann Epidemiol
, vol.7
, pp. 322-333
-
-
Williams, D.R.1
-
23
-
-
0030587798
-
The medicalization of race: Scientific legitimization of a flawed social construct
-
Witzig R. The medicalization of race Scientific legitimization of a flawed social construct. Ann Intern Med. 125:1996;675-679
-
(1996)
Ann Intern Med
, vol.125
, pp. 675-679
-
-
Witzig, R.1
|